Furosemide 100 mg added to 0.9% Sodium Chloride 100 mL Injection, 100 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205, 877.550.5059, barcode 70004063032.

Recall Insight

This FDA Drug action (record #D-1189-2018) was formally reported on September 19, 2018, with the manufacturer initiating the action on August 27, 2018. It is classified under Critical severity (Class I), with a current status of Terminated. SCA Pharmaceuticals, Inc. is listed as the recalling firm, operating out of Little Rock, AR. Federal records indicate 1384 bags units are affected.

The documented reason for this recall is: Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide. Distribution data in the federal record shows the product reached: Three hospitals in DC, VA, CT. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls, of which 5 were also issued by FDA Drug. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 8 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.